MASLD involves the accumulation of ceramides and diacylglycerols due to excessive free fatty acid accumulation, triggering insulin resistance through insulin receptor dysfunction and downstream signaling pathways (46). This evidence concerns the gene INSR and metabolic dysfunction-associated steatotic liver disease.